0.777
price down icon5.26%   -0.0431
after-market After Hours: .79 0.013 +1.67%
loading

Atossa Therapeutics Inc Stock (ATOS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
22.61%
6.98
9.019 7.468 7.793 7.098
Operating Income/Loss
22.61%
-6.98
-9.019 -7.468 -7.793 -7.098
Income/Loss From Continuing Operations Before Tax
24.19%
-5.878
-7.754 -6.229 -9.83 -6.281
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
24.19%
-5.878
-7.754 -6.229 -9.83 -6.281
Net Income/Loss
24.19%
-5.878
-7.754 -6.229 -9.83 -6.281
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
47,859%
125.32
-0.2624 125.79 126.62 126.62
Diluted Average Shares
125.32
- - - -
Basic Earnings Per Share
16.67%
-0.05
-0.06 -0.05 -0.08 -0.05
Diluted Earnings Per Share
-0.05
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):